Freight Technologies Announces Strategic Agreement to Advance Agentic AI Initiative

Freight Technologies (Nasdaq: FRGT) said it launched native CFDI (timbrado) invoicing in its Fleet Rocket TMS for Pro and Enterprise subscribers. The feature embeds Mexico SAT e-invoicing, automating CFDI stamping, invoice issuance and cancellation, and generating electronic payment receipts (complemento de pago) via a certified stamping provider. FRGT shares fell 4.57% after the announcement.

Freight Technologies, Inc. (Nasdaq: FRGT) said it completed further workforce reductions and scaled back brokerage operations as it pivots to a pure-play AI software logistics model. The company raised $1.2 million via Series C preferred shares, expecting about $1.15 million net proceeds, and expects ~$0.4 million restructuring costs. It also cited a prior $2.5 million loan to repay its credit facility.

Pinterest's CFO Julia Donnelly will leave on October 30, with an external search underway for her replacement. Interim CFO will be Vikram Naidu. Donnelly's tenure saw 11 quarters of double-digit revenue growth and key partnerships. Pinterest recently forecast slower Q3 revenue growth due to competitive pressures in digital advertising.

NexGen Energy (NXE) is in talks with BHP Group (BHP) for a potential equity stake and financing for its Rook I uranium project. NexGen aims to raise $1 billion over nine months. BHP reported strong financials, with $33 billion in EBITDA and $9.8 billion in free cash flow. NexGen has no revenue but holds $970.25 million in cash. Investors should watch for a formal partnership between the two.

Targa Resources (TRGP) and ExxonMobil (XOM) signed 20-year midstream agreements. TRGP reported Q2 2026 revenue of $4.44B and net income of $764.6M, while XOM reported $116B in revenue and $14.5B in net income. TRGP focuses on fee-based margins, while XOM benefits from scale and diversified operations. Institutional investors reduced holdings in both companies.

At the American Chemical Society Fall 2026 meeting, 13 new drug candidates were unveiled by various companies, targeting diseases like cancer, lupus, and acne. Presenters included Quanta Therapeutics, AstraZeneca, Novartis, and Pfizer, among others, discussing their drug discovery strategies and clinical trials.